DPP4 and Crohn disease: In a separate study, the expression of dipeptidyl peptidase-4 (that inactivates GLP-1) was found to be significantly reduced in tissue and plasma from patients with active Crohn’s Disease, potentially elevating and enhancing the effects of GLP-1 [46].